Matches in Wikidata for { <http://www.wikidata.org/entity/Q38375429> ?p ?o ?g. }
- Q38375429 description "2017 nî lūn-bûn" @default.
- Q38375429 description "2017年の論文" @default.
- Q38375429 description "2017年論文" @default.
- Q38375429 description "2017年論文" @default.
- Q38375429 description "2017年論文" @default.
- Q38375429 description "2017年論文" @default.
- Q38375429 description "2017年論文" @default.
- Q38375429 description "2017年论文" @default.
- Q38375429 description "2017年论文" @default.
- Q38375429 description "2017年论文" @default.
- Q38375429 description "2017年论文" @default.
- Q38375429 description "2017年论文" @default.
- Q38375429 description "2017年论文" @default.
- Q38375429 description "2017년 논문" @default.
- Q38375429 description "article científic" @default.
- Q38375429 description "article scientific" @default.
- Q38375429 description "article scientifique" @default.
- Q38375429 description "articol științific" @default.
- Q38375429 description "articolo scientifico" @default.
- Q38375429 description "artigo científico" @default.
- Q38375429 description "artigo científico" @default.
- Q38375429 description "artigo científico" @default.
- Q38375429 description "artikel ilmiah" @default.
- Q38375429 description "artikull shkencor" @default.
- Q38375429 description "artikulong pang-agham" @default.
- Q38375429 description "artykuł naukowy" @default.
- Q38375429 description "artículo científico" @default.
- Q38375429 description "artículu científicu espublizáu en 2017" @default.
- Q38375429 description "bilimsel makale" @default.
- Q38375429 description "bài báo khoa học" @default.
- Q38375429 description "naučni članak" @default.
- Q38375429 description "scienca artikolo" @default.
- Q38375429 description "scientific article published on 22 March 2017" @default.
- Q38375429 description "scientific article published on 22 March 2017" @default.
- Q38375429 description "scientific article published on 22 March 2017" @default.
- Q38375429 description "teaduslik artikkel" @default.
- Q38375429 description "tieteellinen artikkeli" @default.
- Q38375429 description "tudományos cikk" @default.
- Q38375429 description "vedecký článok" @default.
- Q38375429 description "vetenskaplig artikel" @default.
- Q38375429 description "videnskabelig artikel" @default.
- Q38375429 description "vitenskapelig artikkel" @default.
- Q38375429 description "vitskapeleg artikkel" @default.
- Q38375429 description "vědecký článek" @default.
- Q38375429 description "wetenschappelijk artikel" @default.
- Q38375429 description "wissenschaftlicher Artikel" @default.
- Q38375429 description "επιστημονικό άρθρο" @default.
- Q38375429 description "мақолаи илмӣ" @default.
- Q38375429 description "наукова стаття, опублікована в березні 2017" @default.
- Q38375429 description "научна статия" @default.
- Q38375429 description "научная статья" @default.
- Q38375429 description "научни чланак" @default.
- Q38375429 description "научни чланак" @default.
- Q38375429 description "מאמר מדעי" @default.
- Q38375429 description "مقالة علمية نشرت في 22 مارس 2017" @default.
- Q38375429 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38375429 description "บทความทางวิทยาศาสตร์" @default.
- Q38375429 description "სამეცნიერო სტატია" @default.
- Q38375429 name "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib." @default.
- Q38375429 name "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib." @default.
- Q38375429 name "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib." @default.
- Q38375429 type Item @default.
- Q38375429 label "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib." @default.
- Q38375429 label "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib." @default.
- Q38375429 label "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib." @default.
- Q38375429 prefLabel "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib." @default.
- Q38375429 prefLabel "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib." @default.
- Q38375429 prefLabel "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib." @default.
- Q38375429 P1433 Q38375429-77BFEAF7-9C97-44A0-B708-D382DFA8CCEA @default.
- Q38375429 P1476 Q38375429-7049EEF6-E27F-4221-8710-22D106221981 @default.
- Q38375429 P2093 Q38375429-420A9E1C-3C94-406E-8C41-6EAEDFED576F @default.
- Q38375429 P2093 Q38375429-456F8046-8429-4AC7-AD3B-45F5E43D9BDF @default.
- Q38375429 P2093 Q38375429-6DF0AB6C-A347-4C45-8DE8-BDD9B8F8AA39 @default.
- Q38375429 P2093 Q38375429-77B5FCBC-D3AD-413F-AEE7-F560C1650401 @default.
- Q38375429 P2093 Q38375429-790CD555-7080-4879-A5F6-079D147DBAED @default.
- Q38375429 P2093 Q38375429-7D6A672D-5DAA-492D-B047-10AA2A0A885C @default.
- Q38375429 P2093 Q38375429-94D152CB-604B-4ABD-9DF4-30AC0B05EBAB @default.
- Q38375429 P2093 Q38375429-AA16CBF4-A90A-41A3-8914-1A6A36EF561F @default.
- Q38375429 P2093 Q38375429-B488EBE6-A5DE-4FC6-9322-575A5DB3969D @default.
- Q38375429 P2093 Q38375429-D52D2C3C-D544-445F-A271-EFFD64AA2873 @default.
- Q38375429 P2093 Q38375429-E037E0DC-3942-4834-A086-66DAC4280F2D @default.
- Q38375429 P2093 Q38375429-E3CB49FB-2F09-437D-A815-5AD59E6BD089 @default.
- Q38375429 P304 Q38375429-8135971B-2B14-4BF6-87DA-311FF7336807 @default.
- Q38375429 P31 Q38375429-2D673CB8-5B61-4F60-B5B1-AB43B7CBF18B @default.
- Q38375429 P356 Q38375429-407132DC-F6C8-4F7E-85E2-D23AADDA2711 @default.
- Q38375429 P407 Q38375429-E00D1396-B53A-469E-BB95-1117722637BC @default.
- Q38375429 P478 Q38375429-3027825A-EE4D-4B76-8FDD-5B1A87D476D2 @default.
- Q38375429 P50 Q38375429-1AE70CC6-43E1-4834-BAAA-231E5E575CDE @default.
- Q38375429 P50 Q38375429-CB470FBC-4718-4799-8CE1-DEA037344A49 @default.
- Q38375429 P577 Q38375429-216D0830-E43E-41FC-A00D-0DA86D6A1CAE @default.
- Q38375429 P698 Q38375429-A591B1F9-7900-442B-97D0-39FD5AC9535D @default.
- Q38375429 P921 Q38375429-95046CF4-30B6-4705-AF61-811F17804BE7 @default.
- Q38375429 P356 J.LUNGCAN.2017.03.009 @default.
- Q38375429 P698 28625629 @default.
- Q38375429 P1433 Q641464 @default.
- Q38375429 P1476 "A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib" @default.
- Q38375429 P2093 "Amelia Insa" @default.
- Q38375429 P2093 "Chooi Lee" @default.
- Q38375429 P2093 "David Schnell" @default.
- Q38375429 P2093 "Dolores Isla" @default.